SEI Investments’s Vor Biopharma VOR Stock Holding History

SEI Investments’s Portfolio VOR Stock Details VOR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$424K	Buy	23,019 +9,303	+68%	+$141K	﹤0.01%	2711
2026 Q1	$245K	Buy	+13,716	New	+$193K	﹤0.01%	2895
2024 Q3	–	Sell	-880	Closed	-$17.6K	–	2773
2024 Q2	$17.6K	Buy	+880	New	+$28.5K	﹤0.01%	2637

Other funds holding VOR

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

FIS

FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return

SEI Investments's VOR Position: Q2 2026 in Review

SEI Investments increased its Vor Biopharma (VOR) stake by 68% in Q2 2026, buying an estimated $141K and bringing the position to 23,019 shares worth $424K. The position accounts for ﹤0.01% of the portfolio, ranked #2711.

SEI Investments first reported a position in VOR in Q2 2024 and has held it in 3 quarters since. 102 funds tracked by Wall St. Rank hold VOR as of Q2 2026.

SEI Investments held 23,019 shares of Vor Biopharma worth $424K as of Q2 2026.
SEI Investments bought 9,303 Vor Biopharma shares in Q2 2026, an estimated $141K.
Vor Biopharma made up ﹤0.01% of SEI Investments's portfolio in Q2 2026, its #2711 holding.
SEI Investments first reported a position in Vor Biopharma in Q2 2024 and has held it in 3 quarters since.
102 funds tracked by Wall St. Rank held Vor Biopharma as of Q2 2026.

Based on SEI Investments's 13F filing for Q2 2026, filed 14 Aug 2026.